达芬奇机器人手术系统在非小细胞肺癌手术中的成本效益分析  

Cost-effectiveness analysis of Da Vinci robot-assisted surgery for non-small cell lung cancer

作　　者：王树民 李飞[2] 褚恒 张哲[2] WANG Shumin;LI Fei;CHU Heng;ZHANG Zhe(School of Clinical Medicine,Shandong Second Medical University,Weifang 261053,China;Department of Thoracic Surgery,Qingdao Municipal Hospital,Qingdao 266071,China)

机构地区：[1]山东第二医科大学临床医学院,山东潍坊261053 [2]青岛市市立医院胸外科,山东青岛266071

出　　处：《机器人外科学杂志(中英文)》2025年第1期149-154,共6页Chinese Journal of Robotic Surgery

基　　金：国家自然科学基金(22204152)。

摘　　要：随着微创手术的不断发展和普及,手术机器人凭借其精密的机械控制系统、高清的成像以及灵活的机械臂在外科领域广泛应用。机器人辅助手术在淋巴结清扫、围手术期指标和术后并发症等方面较胸腔镜手术更具优势,但其手术成本较高。然而对于复杂的肺部相关手术,机器人辅助手术可通过缩短住院时间,降低术后并发症发生率,减少术后住院费用等方式,满足患者需求的同时获得更高的成本效益。本文阐述了机器人辅助胸腔镜手术在非小细胞肺癌患者中的应用现状,探讨其成本效益,并对达芬奇机器人手术系统在非小细胞肺癌领域的发展前景进行展望。With the continuous development and popularization of minimally invasive surgery,surgical robots are widely used in the surgical field,relying on their sophisticated mechanical control systems,high-definition imaging,and flexible robotic arms.Robot-assisted surgery is superior to thoracoscopic surgery in terms of lymph node dissection,improvement of perioperative indices,and reduction of postoperative complications,but it is more costly.However,for complex pulmonary surgeries,robot-assisted surgery can meet the needs of patients and achieve higher cost-effectiveness by shortening the length of hospital stay,reducing the incidence of postoperative complications,and decreasing postoperative hospitalization costs.This paper describes the current application status of robot-assisted thoracoscopic surgery in patients with non-small cell lung cancer(NSCLC),discusses its cost-effectiveness,and foresees the development of the Da Vinci robotic surgical system in the field of NSCLC.

关 键 词：非小细胞肺癌 机器人辅助胸腔镜手术 电视胸腔镜手术 成本效益 

分 类 号：R608[医药卫生—外科学] R734.2[医药卫生—临床医学]